Biofrontera Inc. (BFRI) News

Biofrontera Inc. (BFRI): $2.80

0.19 (+7.28%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter BFRI News Items

BFRI News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

BFRI News Highlights

  • BFRI's 30 day story count now stands at 2.
  • Over the past 8 days, the trend for BFRI's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
  • GRAB and III are the most mentioned tickers in articles about BFRI.

Latest BFRI News From Around the Web

Below are the latest news stories about Biofrontera Inc that investors may wish to consider to help them evaluate BFRI as an investment opportunity.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Good morning, trader!

William White on InvestorPlace | February 23, 2022

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Rise and shine, trader!

William White on InvestorPlace | February 17, 2022

Biofrontera Inc. provides Update on Patient Recruitment for Phase III Study for the Treatment of sBCC with Ameluz®-PDT

WOBURN, Mass., Feb. 01, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (the “Company”), a biopharmaceutical company specializing in the commercialization of dermatological products, is pleased to provide an update on the patient recruitment for the phase III clinical study for the treatment of superficial basal cell carcinoma (sBCC) with Ameluz® photodynamic therapy (Ameluz®-PDT) in combination with the BF-RhodoLED® lamp in the U.S. To date, 70% of the planned 186 patients have been en

Yahoo | February 1, 2022

Biofrontera Inc. Issues Letter to Shareholders Highlighting 2021 Successes and Key Elements of the Strategic Plan for 2022 and Beyond

WOBURN, Mass., Jan. 18, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (the “Company”), a biopharmaceutical company specializing in the commercialization of dermatological products, today issued the following letter from CEO Erica Monaco and Executive Chairman of the Board Hermann Lübbert. To our valued stockholders, We would like to extend warm wishes to all of you for a healthy and prosperous 2022. At Biofrontera Inc., we welcomed the New Year with optimism and continued business mom

Yahoo | January 18, 2022

Biofrontera Inc. Announces Preliminary Revenue for the Fourth Quarter and Full Year 2021

WOBURN, Mass., Jan. 13, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (the “Company”), a biopharmaceutical company specializing in the commercialization of dermatological products, today announced preliminary, unaudited revenue for the quarter and full year ended December 31, 2021. Revenue for the fourth quarter of 2021 is anticipated to be in the range of approximately $9.1 million to $9.2 million, an increase of approximately 7% over the same quarter last year. Revenue for the full

Yahoo | January 13, 2022

Biofrontera Inc. Announces Participation in Two Dermatology Conferences in January

WOBURN, Mass., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (the “Company”), a biopharmaceutical company specializing in the commercialization of dermatological products, announced today that it plans to participate in the following two dermatology conferences in January: 2022 Winter Clinical Dermatology Conference at the Grand Hyatt in Kauai, January 14-19, 2022Maui Derm for Dermatologists 2022 at the Grand Wailea, January 24-28, 2022 At each conference, clinical data for B

Yahoo | January 10, 2022

Biofrontera Inc. announces reduction of Biofrontera AG shareholding to less than 50% through warrant exercises

WOBURN, Mass., Dec. 30, 2021 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announced that through the exercise of outstanding warrants the majority ownership of Biofrontera AG was diluted below 50%. Biofrontera AG’s shareholding in Biofrontera Inc. of 8,000,000 shares is unchanged, but now represents approximately 47% of the currently outstanding shares. As a result, Biofrontera Inc. is no longer

Yahoo | December 30, 2021

BFRI Stock Alert: The Social Media Chatter That Has Biofrontera Booming Today

Biofrontera (BFRI) stock is on the move today as traders take to Twitter (TWTR) to discuss the latest news surrounding the company.

William White on InvestorPlace | December 21, 2021

BRZE Stock: 16 Reasons Why Newly Public Braze Is Bouncing Higher Today

Braze (BRZE) stock is on the move Tuesday after the company released its earnings report for the third quarter of the year.

William White on InvestorPlace | December 21, 2021

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Good morning, trader!

William White on InvestorPlace | December 21, 2021


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6573 seconds.